Inventor
ROBBINS PAUL F
US20 patents
⚠️ This page may combine multiple inventors who share the name “ROBBINS PAUL F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
17 patentsUS5843648ADec 1, 1998
P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
US HEALTH33 citations92
US9879065B2Jan 30, 2018
T cell receptors recognizing MHC class II-restricted MAGE-A3
US HEALTH11 citations84
US11208456B2Dec 28, 2021
Anti-KRAS-G12D T cell receptors
US HEALTH8 citations82
US10611816B2Apr 7, 2020
Anti-KRAS-G12D T cell receptors
US HEALTH9 citations82
US10611815B2Apr 7, 2020
T cell receptors recognizing MHC class II-restricted MAGE-A3
US HEALTH1 citations73
US6951917B1Oct 4, 2005
MHC-class II restricted melanoma antigens and their use in therapeutic methods
US HEALTH8 citations73
US11897933B2Feb 13, 2024
Anti-KRAS-G12D T cell receptors
US HEALTH1 citations71
US11306131B2Apr 19, 2022
T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mage
US HEALTH2 citations69
US12404317B2Sep 2, 2025
T cell receptors recognizing MHC class II-restricted MAGE-A3
US HEALTH0 citations62
US12171818B2Dec 24, 2024
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
US HEALTH0 citations62
US12391742B2Aug 19, 2025
Anti-KRAS-G12D T cell receptors
US HEALTH0 citations61
US11840561B2Dec 12, 2023
Anti-KRAS-G12D T cell receptors
US HEALTH0 citations61
US12441778B2Oct 14, 2025
T cell receptors recognizing HLA-A1-restricted MAGE-A3
US HEALTH0 citations59
US12304940B2May 20, 2025
HLA class II-restricted t cell receptors against mutated RAS
US HEALTH0 citations59
US11306132B2Apr 19, 2022
HLA class II-restricted T cell receptors against mutated RAS
US HEALTH0 citations59
US11939365B2Mar 26, 2024
T cell receptors recognizing mutated P53
US HEALTH1 citations56
US11976299B2May 7, 2024
Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
US HEALTH0 citations44